( March 6, 2025, 12:18 PM EST) -- WASHINGTON, D.C. — The federal government on March 5 moved to dismiss a lawsuit brought by more than 200 individuals whose family members were treated during the COVID-19 pandemic with and allegedly died as a direct result of certain countermeasures such as hydroxychloroquine and azithromycin and alleged that the secretary of the U.S. Department of Health and Human Services (HHS) was applying an incorrect standard for eligibility and to date had found no one eligible for the Countermeasure Injury Compensation Program (CICP) benefits....